盛禾生物控股有限公司（02898）近日发布2026年1月证券变动月报表。公告日期为2026年2月4日，报告期覆盖至2026年1月31日。
根据公告显示，公司法定股本维持为2亿股，面值每股0.0005美元，注册资本总额100,000美元；截至本月底已发行股份总数为156,666,800股，与上月底一致。期内公司无任何新增发行、购回、注销或库藏股变动。
公司同时披露，本月并无期权及股权激励计划、权证或可换股债券等方面的变化。截至报告期末，股本结构未发生实质变动，公众持股量符合适用的香港联交所上市规则要求。
公告由公司主席兼执行董事张峰签署。公司表示将持续遵守香港联交所《上市规则》及相关法规之规定。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.